These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 33101584)

  • 1. Oxidative Stress in Parkinson's Disease: Potential Benefits of Antioxidant Supplementation.
    Percário S; da Silva Barbosa A; Varela ELP; Gomes ARQ; Ferreira MES; de Nazaré Araújo Moreira T; Dolabela MF
    Oxid Med Cell Longev; 2020; 2020():2360872. PubMed ID: 33101584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondria-targeted antioxidants for treatment of Parkinson's disease: preclinical and clinical outcomes.
    Jin H; Kanthasamy A; Ghosh A; Anantharam V; Kalyanaraman B; Kanthasamy AG
    Biochim Biophys Acta; 2014 Aug; 1842(8):1282-94. PubMed ID: 24060637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contributions of antioxidant activity of lipoic acid in reducing neurogenerative progression of Parkinson's disease: a review.
    De Araújo DP; Lobato Rde F; Cavalcanti JR; Sampaio LR; Araújo PV; Silva MC; Neves KR; Fonteles MM; Sousa FC; Vasconcelos SM
    Int J Neurosci; 2011 Feb; 121(2):51-7. PubMed ID: 21126109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coenzyme Q10 for Patients with Parkinson's Disease: A Systematic Review and Meta-Analysis.
    Negida A; Menshawy A; El Ashal G; Elfouly Y; Hani Y; Hegazy Y; El Ghonimy S; Fouda S; Rashad Y
    CNS Neurol Disord Drug Targets; 2016; 15(1):45-53. PubMed ID: 26553164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terpene compounds in nature: a review of their potential antioxidant activity.
    González-Burgos E; Gómez-Serranillos MP
    Curr Med Chem; 2012; 19(31):5319-41. PubMed ID: 22963623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antioxidants as therapy for Parkinson's disease.
    Shults CW
    Antioxid Redox Signal; 2005; 7(5-6):694-700. PubMed ID: 15890014
    [No Abstract]   [Full Text] [Related]  

  • 7. Cellular and molecular mechanisms of antioxidants in Parkinson's disease.
    Sutachan JJ; Casas Z; Albarracin SL; Stab BR; Samudio I; Gonzalez J; Morales L; Barreto GE
    Nutr Neurosci; 2012 May; 15(3):120-6. PubMed ID: 22732354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maillard reaction, mitochondria and oxidative stress: potential role of antioxidants.
    Edeas M; Attaf D; Mailfert AS; Nasu M; Joubet R
    Pathol Biol (Paris); 2010 Jun; 58(3):220-5. PubMed ID: 20031340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment.
    Beal MF
    J Bioenerg Biomembr; 2004 Aug; 36(4):381-6. PubMed ID: 15377876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidant compound supplementation prevents oxidative damage in a Drosophila model of Parkinson's disease.
    Casani S; Gómez-Pastor R; Matallana E; Paricio N
    Free Radic Biol Med; 2013 Aug; 61():151-60. PubMed ID: 23548634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of hesperidin in a model of Parkinson's disease induced by 6-hydroxydopamine in aged mice.
    Antunes MS; Goes AT; Boeira SP; Prigol M; Jesse CR
    Nutrition; 2014; 30(11-12):1415-22. PubMed ID: 25280422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondria-targeted antioxidant MitoQ reduces gentamicin-induced ototoxicity.
    Ojano-Dirain CP; Antonelli PJ; Le Prell CG
    Otol Neurotol; 2014 Mar; 35(3):533-9. PubMed ID: 24518411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plant Polyphenols as Neuroprotective Agents in Parkinson's Disease Targeting Oxidative Stress.
    Hor SL; Teoh SL; Lim WL
    Curr Drug Targets; 2020; 21(5):458-476. PubMed ID: 31625473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effect of naphtha[1,2-d]thiazol-2-amine in an animal model of Parkinson's disease.
    Azam F; Barodia SK; Anwer T; Alam MM
    J Enzyme Inhib Med Chem; 2009 Jun; 24(3):808-17. PubMed ID: 18846462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress and Parkinson's disease: conflict of oxidant-antioxidant systems.
    Hemmati-Dinarvand M; Saedi S; Valilo M; Kalantary-Charvadeh A; Alizadeh Sani M; Kargar R; Safari H; Samadi N
    Neurosci Lett; 2019 Sep; 709():134296. PubMed ID: 31153970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of neuromotor deficits by natural antioxidants of Decalepis hamiltonii in transgenic Drosophila model of Parkinson's disease.
    Jahromi SR; Haddadi M; Shivanandappa T; Ramesh SR
    Neuroscience; 2015 May; 293():136-50. PubMed ID: 25754960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Antioxidants in the Therapy of Cardiovascular Diseases-A Literature Review.
    Młynarska E; Hajdys J; Czarnik W; Fularski P; Leszto K; Majchrowicz G; Lisińska W; Rysz J; Franczyk B
    Nutrients; 2024 Aug; 16(16):. PubMed ID: 39203723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective role of vitamin E on the oxidative stress in Hansen's disease (Leprosy) patients.
    Vijayaraghavan R; Suribabu CS; Sekar B; Oommen PK; Kavithalakshmi SN; Madhusudhanan N; Panneerselvam C
    Eur J Clin Nutr; 2005 Oct; 59(10):1121-8. PubMed ID: 16015260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondria, oxidative damage, and inflammation in Parkinson's disease.
    Beal MF
    Ann N Y Acad Sci; 2003 Jun; 991():120-31. PubMed ID: 12846981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ameliorative effect of Monascus purpureus NTU 568-fermented rice extracts on 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells and the rat model of Parkinson's disease.
    Tseng WT; Hsu YW; Pan TM
    Food Funct; 2016 Feb; 7(2):752-62. PubMed ID: 26809317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.